Roots Analysis is pleased toannounce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.
The report featuresan extensive study of the current market landscape of gene therapies, primarilyfocusing on gene augmentation-based therapies, oncolytic viral therapies,immunotherapies and gene editing therapies. The study also features anelaborate discussion on the future potential of this evolving market. Inaddition to other elements, the study includes:
§ A detailed review ofthe overall market landscape of gene therapies and gene editing therapies,including information on phase of development of pipeline candidates, keytherapeutic areas, target disease indication(s), type of vector used, type ofgene, type of modification, type of gene therapy, route of administration andspecial drug designation(s) awarded (if any).
§ A detailed review ofthe players engaged in the development of gene therapies.
§ An elaboratediscussion on the various types of viral and non-viral vectors.
§ A discussion on theregulatory landscape related to gene therapies across various geographies,namely North America, Europe and Asia-Pacific.
§ Detailed profiles ofmarketed and late stage (phase II/III and above) gene therapies.
§ An elaboratediscussion on the various commercialization strategies that can be adopted bydrug developers across different stages of therapy development.
§ A review of thevarious emerging technologies and therapy development platforms that are beingused to design and manufacture gene therapies.
§ An in-depth analysisof various patents that have been filed / granted related to gene therapies andgene editing therapies, since 2016.
§ A detailed analysisof the various mergers and acquisitions that have taken place within thisdomain, during the period 2015-2020.
§ An analysis of theinvestments made at various stages of development in companies that are focusedin this area, between 2015-2020.
§ A detailedgeographical clinical trial analysis of completed, ongoing and planned studiesof numerous gene therapies.
§ An analysis of thevarious factors that are likely to influence the pricing of gene therapies.
§ An analysis of thebig biopharma players engaged in this domain.
§ An informed estimateof the annual demand for gene therapies.
§ A case study on theprevalent and emerging trends related to vector manufacturing.
§ A discussion on thevarious operating models adopted by gene therapy developers for supply chainmanagement.
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
- Therapeutic Approach
§ Geneaugmentation
§ Oncolytictherapy
§ Immunotherapy
§ Others
- Type of gene therapy
§ Exvivo
§ Invivo
- Type of vector used
§ Adenoassociated virus
§ Adenovirus
§ Herpessimplex virus
§ Lentivirus
§ PlasmidDNA
§ Retrovirus
§ Others
- Key therapeutic areas
§ Autoimmune disorders
§ Cardiovasculardiseases
§ Dermatologicaldisorders
§ Genetic disorders
§ Hematologicaldisorders
§ Metabolic disorders
§ Muscle-relateddiseases
§ Oncological disorders
§ Ophthalmic diseases
§ Others
- Route of administration
§ Intraarticular
§ Intracerebellar
§ Intradermal
§ Intramuscular
§ Intratumoral
§ Intravenous
§ Intravesical
§ Intravitreal
§ Subretinal
§ Others
- Key geographical regions
§ North America
§ Europe
§ Asia-Pacific
Key companies covered in the report
§ Abeona Therapeutics
§ Advantagene
§ Biogen
§ bluebird bio
§ Castle Creek Biosciences
§ CG Oncology
§ FerGene
§ Freeline Therapeutics
§ Gradalis
§ Helixmith
§ Inovio Pharmaceuticals
§ Kolon TissueGene
§ Krystal Biotech
§ Lysogene
§ Neurophth Therapeutics
§ OncoSec Immunotherapies
§ Orchard Therapeutics
§ Pfizer
§ Sangamo Therapeutics
§ Spark Therapeutics
§ uniQure Biopharma
§ VBL Therapeutics
For more information, pleaseclick on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html
Other RecentOfferings
1. ViralVectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4thEdition), 2021-2030
2. GlobalT-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030
3. OncolyticVirus Therapy Market: Pipeline Review, Developer Landscape and CompetitiveInsights, 2020-2030
About Roots Analysis
Roots Analysis is oneof the fastest growing market research companies, sharing fresh and independentperspectives in the bio-pharmaceutical industry. The in-depth research,analysis and insights are driven by an experienced leadership team which hasgained many years of significant experience in this sector. If you’d like helpwith your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots AnalysisPrivate Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
